Highlights and Quick Summary
- Annual ROA for 2021 was -65.55% (a -2.47% decrease from previous year)
- Annual ROA for 2020 was -67.21% (a 41.41% increase from previous year)
- Annual ROA for 2019 was -47.53% (a -15.49% decrease from previous year)
- Twelve month ROA ending September 30, 2022 was -64.96% (a 23.92% increase compared to previous quarter)
- Twelve month trailing ROA decreased by -0.88% year-over-year
Trailing ROA for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| -64.96% | -52.42% | -62.51% | -65.54% |
Visit stockrow.com/BBIO
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical ROA of BridgeBio Pharma, Inc.
Most recent ROAof BBIO including historical data for past 10 years.Interactive Chart of ROA of BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. ROA for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | – | – | – | – | -65.55% |
| 2020 | – | – | – | – | -67.21% |
| 2019 | – | – | – | – | -47.53% |
| 2018 | – | – | – | – | -56.24% |
| 2017 | – | – | – | – | -10.86% |
Business Profile of BridgeBio Pharma, Inc.
Sector: Healthcare
Industry: Biotechnology